Metabolic profiling of angiopoietin-like protein 3 and 4 inhibition: a drug-target Mendelian randomization analysis | Marea Therapeutics

Marea Therapeutics

About
Science
Pipeline
Careers
News

12/22/2020

Share

About
Careers
Home
News
Pipeline
Privacy Policy
Science
Terms and Conditions